Previous Article | Next Article 
Journal of Clinical Microbiology, June 1999, p. 1948-1952, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
High-Resolution Genotyping of Streptococcus pyogenes
Serotype M1 Isolates by Fluorescent Amplified-Fragment Length
Polymorphism Analysis
Meeta
Desai,1
Androulla
Efstratiou,2
Robert
George,2 and
John
Stanley1,*
Molecular Biology Unit, Virus Reference
Division,1 and Streptococcus and
Diphtheria Reference Unit, WHO Collaborating Centre for Diphtheria
and Streptococcal Infections,2 Central
Public Health Laboratory, London NW9 5HT, United Kingdom
Received 11 September 1998/Returned for modification 17 December
1998/Accepted 17 March 1999
 |
ABSTRACT |
We have used fluorescent amplified-fragment length polymorphism
(FAFLP) analysis to subtype clinical isolates of Streptococcus pyogenes serotype M1. Established typing methods define most M1 isolates as members of a clone that has a worldwide distribution and
that is strongly associated with invasive diseases. FAFLP analysis
simultaneously sampled 90 to 120 loci throughout the M1 genome. Its
discriminatory power, precision, and reproducibility were compared with
those of other molecular typing methods. Irrespective of disease
symptomatology or geographic origin, the majority of the clinical M1
isolates shared a single ribotype, pulsed-field gel electrophoresis
macrorestriction profile, and emm1 gene sequence. Nonetheless, among these isolates, FAFLP analysis could differentiate 17 distinct profiles, including seven multi-isolate groups. The FAFLP profiles of M1 isolates reproducibly exhibited between 1 and
more than 20 amplified fragment differences. The high discriminatory power of genotyping by FAFLP analysis revealed genetic
microheterogeneity and differentiated otherwise "identical" M1
isolates as members of a clone complex.
 |
INTRODUCTION |
Streptococcus pyogenes,
the group A streptococcus (GAS), is the etiological agent of diverse
invasive and noninvasive diseases. A primary virulence factor, the M
protein, is encoded by the emm gene and provides the basis
for seroepidemiology (11, 12).
The last 10 years have seen a worldwide resurgence of severe invasive
GAS disease caused predominantly by serotypes M1 and M3. M1 has been
strongly associated with rapidly fulminating invasive infections
(21). The Public Health Laboratory Service Enhanced Surveillance Study of invasive GAS infections (1994 to 1997) for England and Wales (Fig. 1) indicated an
increase, with the overall predominant serotype (30%) being M1
(6). A similar proportion of M1 infections has been reported
in North America (3).

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Proportion of invasive GAS disease due to serotype M1
over a 2-year period (PHLS Enhanced Surveillance Study data
[6]). Open columns and numbers represent the total of
invasive GAS infections, while the shaded areas indicate the percentage
of infections caused by M1 isolates.
|
|
Cleary et al. (2) reported on the worldwide emergence of a
highly virulent M1 "clone" expressing the streptococcal pyogenic exotoxin A (SPEA). Musser et al. (15) further characterized the genotype of this M1 "subclone" as multilocus electropherotype ET1 and pulsed-field gel electrophoresis (PFGE) type 1a and found that
all members of the subclone possessed identical sequences for the
emm1, speA, and ska genes. It was
identified from many patients with invasive disease in Finland and
Norway (13).
Established molecular methods previously applied to GAS include
multilocus enzyme electrophoresis (14), restriction
endonuclease analysis (2), ribotyping (19),
PCR-restriction fragment length polymorphism (PCR-RFLP) analysis or
sequencing of the emm gene (1, 19), and PFGE
(18, 20).
Amplified-fragment length polymorphism analysis, a PCR-based technique
(25), has been used with radioactive labelling to demonstrate strain heterogeneity in several bacterial genera (9, 10, 24). Those studies made no attempt to quantify its
discriminatory power. We have previously shown that fluorescent
amplified-fragment length polymorphism (FAFLP) analysis, in which one
PCR primer is labelled with a fluorescent dye and the products are
separated on an automated DNA sequencer, can successfully resolve a
cluster of isolates recovered from a temporally and geographically
related outbreak of GAS (5). The objective of the present
study, on the other hand, was to establish whether FAFLP analysis could accurately and reproducibly demonstrate microheterogeneity within a
"strain" which by all other molecular techniques was regarded as a
clone. We chose to analyze the established M1 subclone of S. pyogenes and compare FAFLP analysis with existing molecular typing methods.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
The type strain
(NCTC 8198), 2 reference strains (NCTC 2218 and NCTC 8370), and 37 clinical isolates (recovered from 1994 to 1995) of S. pyogenes serotype M1 were analyzed (Table 1). Clinical isolates
were from the Streptococcus and Diphtheria Reference Unit, while type
and reference strains were from the National Collection of Type
Cultures (NCTC; Central Public Health Laboratory, London, United
Kingdom). These 3 strains and 35 of the 37 clinical isolates contained
the pyrogenic exotoxin gene speA. All 40 lacked the
insertion element IS1239 (19). Streptococci were
cultured aerobically at 37°C for 18 to 24 h on horse blood agar
plates, and stock cultures were preserved in blood glycerol (16%;
vol/vol) broth (Oxoid, Basingstoke, United Kingdom) at
70°C.
Isolates were serotyped before and after genotyping by conventional
methods (11, 12).
emm gene polymorphism (PCR-RFLP analysis and
sequencing).
The "all-M" PCR primers and conditions of
Podbielski et al. (17) were used to amplify the
emm gene. RFLP analysis of emm1 amplicons was
carried out as described previously (19). All amplicons were
purified with GeneClean (Bio 101) and were subjected to cycle
sequencing with the all-M forward primer of Podbielski et al.
(17) with the PRISM Dye Terminator Cycle Sequencing kit. Analysis was performed on an ABI 373A DNA sequencer.
PFGE and tree construction.
PFGE was carried out following
macrorestriction with three enzymes (SmaI, SfiI,
and NgoAIV) as described previously (4). Genetic
relationships between the isolates were then estimated by applying the
equation of Nei and Li (16) to calculate distance (D) values (additive for all enzymes), and a distance matrix
was constructed. The resulting estimates of overall restriction site similarity were used to construct an unrooted tree by applying the
FITCH option of the PHYLIP computer package (8).
Minipreparation of genomic DNA and 16S ribotyping.
Genomic
DNA was extracted from streptococcal plate cultures as described
previously (20), digested with an endonuclease (XhoI, EcoRI, or SacI),
electrophoresed, blotted, and hybridized with a 1,500-bp S. pyogenes 16S rRNA gene probe as described previously (20). Membrane filters were developed colorimetrically and
were scanned directly (ScanMaker IIG; Microtek Lab, Redondo Beach, Calif.) into a Power Macintosh 6100/60 (Apple Computer, Cupertino, Calif.).
FAFLP analysis.
FAFLP analysis was performed with DNA
extracted from M1 isolates as described previously (5).
FAFLP products were separated on an ABI Prism 377 automated DNA
sequencer as described previously (5), with modifications as
follows. The Premix Long Ranger polyacrylamide gel solution (FMC
BioProducts, Vallensbaek Strand, Denmark) was used for the gel. The
reaction mixtures used for FAFLP analysis were diluted 1:3, and 1.5 µl was added to 3.5 µl of loading dye (2.5 µl of formamide, 0.5 µl of dextran blue, and 0.5 µl of ROX-2500 internal lane standard).
The electrophoresis conditions were as described previously
(5).
 |
RESULTS |
Polymorphism of the emm1 gene.
PCR amplicons were
generated from the emm1 genes of all isolates and analyzed
for HaeIII polymorphisms as described previously (19). Two RFLPs (subtypes 1.H1 and 1.H2) were found
among the 40 isolates. All but one isolate (NCTC 2218) shared subtype
1.H1. The sizes of the two amplicons calculated from the sum of the sizes of the HaeIII fragments were approximately 1,460 bp (emm1.H1) and 1,200 bp (emm1.H2).
The 5' regions (280 bp) of the amplicons from all isolates were
sequenced and aligned with the MegAlign module of the Lasergene software (DNASTAR). All amplicons contained the nucleotide
sequence 5'-TCGCTTAGAAAATTAA-3', which distinguishes
sequences in the conserved regions of the emm genes from the
corresponding regions of enn or mrp genes
(26, 27). Thirty-five of the 39 isolates which exhibited
RFLP subtype 1.H1 had nucleotide sequences identical to that previously
published for the M1 type strain (27). Of the remaining four
amplicons with RFLP subtype 1.H1, two had a single-base substitution
(G
T; 1 at position 144 [isolate R2609] and the other at position
256 [isolate R1968]), one (isolate R2193) had a 3-base deletion (AAA)
at position 34 and a single base substitution at position 80 (A
G),
while the fourth one (isolate R2437) had two single-base substitutions
at position 139 (T
C) and position 144 (G
T). RFLP subtype 1.H2
exhibited 34% sequence divergence from the predominant (and type
strain) emm1.H1 sequence (data not shown).
16S ribotypes.
Two XhoI RFLPs were detected; 95%
of isolates shared one of these ribotypes, ribotype X1. Of two
EcoRI ribotypes detected, 98% of isolates shared ribotype
E1. Among six SacI ribotypes detected, 88% of isolates
shared ribotype S2. By sequential addition of data, six combined
ribotypes were derived; thus, the ribotype for isolates with
ribotypes E1, X1, and S1 was termed combined ribotype R-1,
while the ribotype for those with ribotypes E11, X2, and S24 was termed
combined ribotype R-6. By this analysis, 35 M1 isolates were found to
share combined ribotype R-2. The remaining five isolates, four of which
had early isolation dates, had unique combined ribotypes.
PFGE and macrorestriction profiles.
Six macrorestriction
profiles (mrps) were found among the 40 isolates with SmaI,
six were found with SfiI, and six were found with
NgoAIV. Eighty-five percent of isolates shared a
principal SmaI mrp and one principal SfiI mrp.
Eighty-eight percent shared one NgoAIV mrp.
The individual mrps obtained with three endonucleases were combined to
give an mrp type (Table
1). Each
designated mrp type
was differentiated by at least three band
differences with at
least one endonuclease. If there were fewer than
three band differences
with any endonuclease, then the type was
designated clonally related
by a postscript letter. For example,
mrp1.6a was related to mrp1.6
by fewer than three band differences in
its
SmaI and
SfiI profiles.
Again, isolates with
SmaI mrp1,
SfiI mrp1, and
NgoAIV mrp1
were
designated mrp1.1, while mrp1.2 represented the combination
SmaI
mrp5,
SfiI mrp4, and
NgoAIV mrp4.
Analysis of genetic relationships by established techniques.
Distance matrices for the three macrorestriction profiles were added
for all isolates and were used to construct a dendrogram (Fig.
2). Its striking feature was that a large
group (34 contemporary isolates) had identical macrorestriction
profiles for all three enzymes. These isolates also shared a ribotype
(R-2) and an emm gene subtype (1.H1). One contemporary
isolate with a minor mrp difference (fewer than three bands) also
carried this emm1 subtype and was therefore considered to be
closely related to the main mrp grouping. The five remaining strains
had distinct mrps and ribotypes. Four strains (isolated in 1950, 1952, 1972, and 1973, respectively) shared emm subtype 1.H1, but
one strain (isolated in 1926) had a unique emm subtype,
subtype 1.H2.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 2.
Dendrogram showing the relationships between serotype M1
isolates, inferred from overall restriction site similarities (on PFGE)
estimated with the equation of Nei and Li (16). These were
used to construct an unrooted tree with the FITCH option of the PHYLIP
package. The corresponding FAFLP profiles are shown in italics, next to
the strain numbers. All isolates except strain NCTC 2218 exhibited
emm1 RFLP type 1.H1.
|
|
FAFLP analysis.
FAFLP analysis with a nonselective primer
(EcoRI+0) and a selective primer (MseI+T)
(5) generated 90 to 120 amplified fragments ranging in size
from 60 to 600 bp. Experiments with a subset of 15 isolates established
that reactions performed from the same DNA extract(s) or from serial
DNA extracts made from the same isolate(s) at different times yielded
reproducible amplified fragment profiles. When these reactions were run
on the same and on different gels, the sizes of the fragments did not
differ by more than 1.0 bp. In-house studies have established the
reproducibility of FAFLP analysis in experiments in which five
different scientists have performed the technique from DNA extraction
to final profiling for the same isolate (3a). Primary
fluorescent band profiles were transformed to electropherograms, and
these were overlaid for visual scrutiny. Peak height is a measure of
the fluorescence detected at a given datum point (±1.0 bp for the ABI
377 automated sequencer). The heights of all peaks constituting a
profile are governed by PCR efficiency and are normalized by the
GeneScan analysis software.
Twenty-two distinct profiles were detected among the 40 isolates.
Fifteen isolates had unique FAFLP profiles; they included
five of the
isolates that were also differentiated by PFGE. The
other 25 isolates
were assigned to seven FAFLP profiles: 6 were
assigned to profile A1, 4 each were assigned to profiles A3, A5,
and A6, 3 were assigned to
profile A7, and 2 each were assigned
to profiles A2 and A4 (Table
1;
Fig.
2). The majority of isolates,
those having mrp1.6 and
emm subtype 1.H1 (i.e., members of the
M1 subclone),
exhibited various combinations of 11 polymorphic
amplified fragments
(summarized in Table
2). Five isolates
with
unique mrp profiles and early isolation dates (Table
1) exhibited
further FAFLP polymorphisms (data not shown).
Examples of areas of FAFLP polymorphism within the M1 subclone are
shown in Fig.
3. These five
electropherograms represent
some of the 17 FAFLP profiles found within
the subclone defined
by PFGE (mrp1.6 or mrp1.6a). For example, FAFLP
profile A1 (Fig.
3, panel 1) contained six characteristic fragments of
73, 129,
316, 365, 367, and 511 bp and lacked five amplified fragments
found in other FAFLP profiles for the subclone. FAFLP profile
A15
contained nine characteristic fragments of 73, 258, 316, 328,
365, 367, 382, 510, and 511 bp, while it lacked two fragments
found in the FAFLP
profiles of other subclones. A fragment of
352 bp was present in M1
subclone isolates but not in all type
and reference strains.
Conversely, fragments of 244, 358, and
364 bp were absent from M1
subclone isolates but were present
in some type and reference strains.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 3.
GeneScan 2.1 software-derived electropherograms showing
examples of areas of polymorphism within FAFLP profiles for
EcoRI+0 plus MseI+T amplifications of five GAS
genomes. Panels 1 to 5 correspond to FAFLP profiles A1, A15, A6, A14,
and A5, respectively. The solid arrowheads and peaks indicate a
fragment characteristic of that profile (sizes are indicated in base
pairs). Open arrowheads indicate the absence of a polymorphic fragment
from that profile.
|
|
 |
DISCUSSION |
We found that 35 contemporary United Kingdom M1 isolates had
identical ribotypes, mrps, and (with two minor variations)
emm1 gene sequences. They were etiological agents of
diseases ranging from pharyngitis to pneumonia and renal disease to
necrotizing fasciitis (Table 1) but could not be differentiated by
published methods. By contrast, FAFLP analysis readily subtyped them,
grouping 25 of the 35 isolates into seven (multi-isolate) profiles and assigning further individual profiles to the remainder of the isolates.
The number of band differences defining FAFLP profiles (within the M1
subclone) varied from 1 to more than 20 (examples are shown in Fig. 3).
These were reproducible and made up of precisely sized (±1.0-bp)
amplified fragments.
The present study is too small to allow us to reach general conclusions
about disease and strain genotype. Nonetheless, we observed three kinds
of associations with multi-isolate FAFLP profiles. These were the
association of profile A1 and all invasive disease isolates, profile A3
and all superficial disease isolates, and profile A6 and a mixture of
invasive and superficial disease isolates. PFGE, by contrast, typed all
M1 subclone isolates into the third (mixed) class. The discriminatory
power and reproducibility of FAFLP analysis therefore offer a valuable
tool for epidemiological analysis of M1. For example, isolates with
identical PFGE profiles from the same geographical area (e.g.,
Nottingham, Blackpool, or Manchester, United Kingdom; Table 1) had
distinct FAFLP profiles and could not have constituted sources of an outbreak.
As further studies are completed, interpretative criteria should be
defined for FAFLP profiles by appropriate interlaboratory and
international collaboration. Criteria for assessment of the genetic
relatedness of PFGE profiles of isolates were proposed (23).
These criteria relate to macrorestriction band shifts on PFGE gels. In
FAFLP analysis, by contrast, even a single fragment which distinguishes
a profile is a PCR amplicon which was precisely sized, reproducibly
found, and amplified under stringent conditions. For either technique,
in clinical and public health practice, the determinants of a profile
cannot be separated from the epidemiological data. The present study
shows that FAFLP analysis found considerable microheterogeneity among
M1 isolates which shared a single PFGE profile and implies that they
constitute a clone complex. Hypervariability of the sic gene
(which encodes the streptococcal inhibitor of complement), recently
found for strains of serotype M1 (22), is concordant with
the FAFLP analysis data. The latter are based on simultaneous PCR
sampling of multiple anonymous loci throughout the genome rather than
one gene.
As the power to characterize strains improves, the number of
differences that can be detected increases and the degree of apparent
clonality recedes (7). The results presented in this study
suggest that FAFLP analysis could subtype other pathogenic bacterial
clones such as epidemic phage types of methicillin-resistant Staphylococcus aureus or of Salmonella
enteritidis.
 |
ACKNOWLEDGMENTS |
We thank Jon Clewley for assistance with the dendrogram and
Philip Mortimer for critically reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Biology Unit, Virus Reference Division, Central Public Health
Laboratory, 61 Colindale Ave., London NW9 5HT, United Kingdom. Phone:
0181 200 4400, ext. 3090. Fax: 0181 200 1569. E-mail:
mdesai{at}hgmp.mrc.ac.uk.
 |
REFERENCES |
| 1.
|
Beall, B.,
R. Facklam, and T. Thompson.
1996.
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.
J. Clin. Microbiol.
34:953-958[Abstract].
|
| 2.
|
Cleary, P. P.,
E. L. Kaplan,
J. P. Handley,
A. Wlazlo,
M. H. Kim,
A. R. Hauser, and P. M. Schlievert.
1992.
Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s.
Lancet
339:518-521[Medline].
|
| 3.
|
Davies, H. D.,
A. McGeer,
B. Schwartz,
K. Green,
D. Cann,
A. Simor,
A. E. Low,
D. E. Low, and Ontario Group A Streptococcal Study Group.
1996.
Invasive group A streptococcal infections in Ontario, Canada.
N. Engl. J. Med.
335:547-554[Abstract/Free Full Text].
|
| 3a.
| Desai, M., and J. Stanley. Unpublished data.
|
| 4.
|
Desai, M.,
A. Tanna,
A. Efstratiou,
R. George,
J. Clewley, and J. Stanley.
1998.
Extensive genetic diversity among clinical isolates of Streptococcus pyogenes serotype M5.
Microbiology
144:629-637[Abstract/Free Full Text].
|
| 5.
|
Desai, M.,
A. Tanna,
R. Wall,
A. Efstratiou,
R. George, and J. Stanley.
1998.
Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease.
J. Clin. Microbiol.
36:3133-3137[Abstract/Free Full Text].
|
| 6.
|
Efstratiou, A.,
R. C. George,
E. T. Gaworzewska,
G. Hallas,
A. Tanna,
W. A. Blake,
M. A. Monnickendam, and M. B. McEvoy.
1997.
Group A streptococcal invasive disease in England and Wales.
Adv. Exp. Med. Biol.
418:207-210[Medline].
|
| 7.
|
Eisenstein, B. I.
1990.
New molecular techniques for microbial epidemiology and the diagnosis of infectious diseases.
J. Infect. Dis.
161:595-602[Medline].
|
| 8.
|
Felsenstein, J.
1988.
PHYLIP: phylogenetic inference package, version 3.0.
University of Washington, Seattle.
|
| 9.
|
Huys, G.,
I. Kersters,
R. Coopman,
P. Janssen, and K. Kersters.
1996.
Genotypic diversity among Aeromonas isolates recovered from drinking water production plants as revealed by AFLPTM analysis.
Syst. Appl. Microbiol.
19:428-435.
|
| 10.
|
Janssen, P.,
R. Coopman,
G. Huys,
J. Swings,
M. Bleeker,
P. Vos,
M. Zabeau, and K. Kersters.
1996.
Evaluation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy.
Microbiology
142:1881-1893[Abstract/Free Full Text].
|
| 11.
|
Johnson, D. R.,
E. L. Kaplan,
J. Sramek,
R. Bicova,
J. Havlicek,
H. Havlickova,
J. Motlova, and P. Kriz.
1996.
Laboratory diagnosis of group A streptococcal infections.
World Health Organization Oriental Press, Geneva, Switzerland.
|
| 12.
|
Lancefield, R. C.
1933.
A serological differentiation of human and other groups of hemolytic streptococci.
J. Exp. Med.
57:571-595[Abstract].
|
| 13.
|
Muotiala, A.,
H. Seppala,
P. Huovinen, and J. Vuopio-Varkila.
1997.
Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland.
J. Infect. Dis.
175:392-399[Medline].
|
| 14.
|
Musser, J. M.,
A. R. Hauser,
M. H. Kim,
P. M. Schlievert,
K. Nelson, and R. K. Selander.
1991.
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.
Proc. Natl. Acad. Sci. USA
88:2668-2672[Abstract/Free Full Text].
|
| 15.
|
Musser, J. M.,
V. Kapur,
J. Szeto,
X. Pan,
D. S. Swanson, and D. R. Martin.
1995.
Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
Infect. Immun.
63:994-1003[Abstract].
|
| 16.
|
Nei, M., and W. Li.
1979.
Mathematical model for studying genetic variation in terms of restriction endonucleases.
Proc. Natl. Acad. Sci. USA
76:5269-5273[Abstract/Free Full Text].
|
| 17.
|
Podbielski, A.,
B. Melzer, and R. Lutticken.
1991.
Application of the polymerase chain reaction to study the M protein (-like) gene family in beta-hemolytic streptococci.
Med. Microbiol. Immunol.
180:213-227[Medline].
|
| 18.
|
Single, L. A., and D. R. Martin.
1992.
Clonal differences within M-types of the group A Streptococcus revealed by pulsed field gel electrophoresis.
FEMS Microbiol. Lett.
70:85-89[Medline].
|
| 19.
|
Stanley, J.,
M. Desai,
J. Xerry,
A. Tanna,
A. Efstratiou, and R. George.
1996.
High-resolution genotyping elucidates the epidemiology of group A streptococcal outbreaks.
J. Infect. Dis.
174:500-506[Medline].
|
| 20.
|
Stanley, J.,
D. Linton,
M. Desai,
A. Efstratiou, and R. George.
1995.
Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease.
J. Clin. Microbiol.
33:2850-2855[Abstract].
|
| 21.
|
Stevens, D. L.
1992.
Invasive group A streptococcus infections.
Clin. Infect. Dis.
14:2-13[Medline].
|
| 22.
|
Stockbauer, K. E.,
D. Grigsby,
X. Pan,
Y. X. Fu,
L. M. Mejia,
A. Cravioto, and J. M. Musser.
1998.
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus.
Proc. Natl. Acad. Sci. USA
95:3128-3133[Abstract/Free Full Text].
|
| 23.
|
Tenover, F. C.,
R. D. Arbeit,
R. V. Goering,
P. A. Mickelsen,
B. E. Murray,
D. H. Persing, and B. Swaminathan.
1995.
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
J. Clin. Microbiol.
33:2233-2239[Medline].
|
| 24.
|
Valsangiacomo, C.,
F. Baggi,
V. Gaia,
T. Balmelli,
R. Peduzzi, and J. Piffaretti.
1995.
Use of amplified fragment length polymorphism in molecular typing of Legionella pneumophila and application to epidemiological studies.
J. Clin. Microbiol.
33:1716-1719[Abstract].
|
| 25.
|
Vos, P.,
R. Hogers,
M. Bleeker,
M. Reijans,
T. van de Lee,
M. Hornes,
A. Frijters,
J. Pot,
J. Peleman,
M. Kulper, and M. Zabeau.
1995.
AFLP: a new technique for DNA fingerprinting.
Nucleic Acids Res.
23:4407-4414[Abstract/Free Full Text].
|
| 26.
|
Whatmore, A. M.,
V. Kapur,
D. J. Sullivan,
J. M. Musser, and M. A. Kehoe.
1994.
Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci.
Mol. Microbiol.
14:619-631[Medline].
|
| 27.
|
Whatmore, A. M., and M. A. Kehoe.
1994.
Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulons.
Mol. Microbiol.
11:363-374[Medline].
|
Journal of Clinical Microbiology, June 1999, p. 1948-1952, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Davignon, L., Walter, E. A., Mueller, K. M., Barrozo, C. P., Stenger, D. A., Lin, B., on behalf of the Epidemic Outbreak Surveillance Co,
(2005). Use of Resequencing Oligonucleotide Microarrays for Identification of Streptococcus pyogenes and Associated Antibiotic Resistance Determinants. J. Clin. Microbiol.
43: 5690-5695
[Abstract]
[Full Text]
-
Whatmore, A. M., Murphy, T. J., Shankster, S., Young, E., Cutler, S. J., Macmillan, A. P.
(2005). Use of Amplified Fragment Length Polymorphism To Identify and Type Brucella Isolates of Medical and Veterinary Interest. J. Clin. Microbiol.
43: 761-769
[Abstract]
[Full Text]
-
Desai, M., Logan, J. M. J., Frost, J. A., Stanley, J.
(2001). Genome Sequence-Based Fluorescent Amplified Fragment Length Polymorphism of Campylobacter jejuni, Its Relationship to Serotyping, and Its Implications for Epidemiological Analysis. J. Clin. Microbiol.
39: 3823-3829
[Abstract]
[Full Text]
-
GRADY, R., BLANC, D., HAUSER, P., STANLEY, J.
(2001). Genotyping of European isolates of methicillin-resistant Staphylococcus aureus by fluorescent amplified-fragment length polymorphism analysis (FAFLP) and pulsed-field gel electrophoresis (PFGE) typing. J Med Microbiol
50: 588-593
[Abstract]
[Full Text]
-
(2001). FAFLP: last word in microbial genotyping?. J Med Microbiol
50: 393-395
[Full Text]
-
Geornaras, I., Hastings, J. W., von Holy, A.
(2001). Genotypic Analysis of Escherichia coli Strains from Poultry Carcasses and Their Susceptibilities to Antimicrobial Agents. Appl. Environ. Microbiol.
67: 1940-1944
[Abstract]
[Full Text]
-
Tamada, Y., Nakaoka, Y., Nishimori, K., Doi, A., Kumaki, T., Uemura, N., Tanaka, K., Makino, S.-I., Sameshima, T., Akiba, M., Nakazawa, M., Uchida, I.
(2001). Molecular Typing and Epidemiological Study of Salmonella enterica Serotype Typhimurium Isolates from Cattle by Fluorescent Amplified-Fragment Length Polymorphism Fingerprinting and Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
39: 1057-1066
[Abstract]
[Full Text]
-
Desai, M., Threlfall, E. J., Stanley, J.
(2001). Fluorescent Amplified-Fragment Length Polymorphism Subtyping of the Salmonella enterica Serovar Enteritidis Phage Type 4 Clone Complex. J. Clin. Microbiol.
39: 201-206
[Abstract]
[Full Text]
-
Lindstedt, B.-A., Heir, E., Vardund, T., Melby, K. K., Kapperud, G.
(2000). Comparative Fingerprinting Analysis of Campylobacter jejuni subsp. jejuni Strains by Amplified-Fragment Length Polymorphism Genotyping. J. Clin. Microbiol.
38: 3379-3387
[Abstract]
[Full Text]
-
DESCHEEMAEKER, P., VAN LOOCK, F., HAUCHECORNE, M., VANDAMME, P., GOOSSENS, H.
(2000). Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994. J Med Microbiol
49: 467-471
[Abstract]
[Full Text]